Paul L. Berns, Director at Jazz Pharmaceuticals plc (JAZZ), sold 1,087 shares at $133.15 ($145K) on 2014-08-12, disclosed to the SEC on 2014-08-14.
Open-market sale of $145k JAZZ by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| NMRA | SELL | 2026-02-19 | $34K | — | Filing → |
| NMRA | SELL | 2025-02-20 | $23K | — | Filing → |
| MTSR | BUY | 2025-02-03 | $14.2M | — | Filing → |